360° Coverage : Hedging Strategies in a Hot Biotech Market (Secrets of the Buy...

1 Updates

Hedging Strategies in a Hot Biotech Market (Secrets of the Buy Side)

Mar 5 2014, 9:20am CST | by

For fun, go to your Bloomberg terminal and pull up a chart for Curagen (CRGN), then type in “GPO M”. This will bring up a price chart from 1998 until the company was acquired by Celldex (CLDX) in...

Filed under: news

 
 
 

25 weeks ago

Hedging Strategies in a Hot Biotech Market (Secrets of the Buy Side)

Mar 5 2014, 9:20am CST | by

For fun, go to your Bloomberg terminal and pull up a chart for Curagen (CRGN), then type in “GPO M”. This will bring up a price chart from 1998 until the company was acquired by Celldex (CLDX) in 2009. Focus on the period from 2000 to 2002.

This is everyone’s biotech bubble nightmare right now.

Is the biotech sector in a bubble? I claim no competence in gauging the wisdom – or whatever you call it – of the masses.

Is the sector “hot?” Undoubtedly.

So what do we do to prevent our portfolios from doing a Curagen?

Protecting stock gains is not as simple a process as one may think (nor is profiting from the reversal of what may be a bullish market for that matter.) You don’t want to depress the price of your stocks by selling your own position, something that portfolio managers face when they own a large position in a relatively illiquid name. Second, while tax considerations should not override fundamentals in trading decisions, they should not be ignored. The United States tax code gives us incentives to hold positions for more than one year, because the tax on capital gains is substantially less than the tax on short-term gains. Third, none of us wants to be overcautious. For those of us who invest based on fundamentals, one stock at a time, we should not overestimate our ability to predict large sector movements when that type of prediction is not a core competence.

So what do we do to prevent our portfolios from doing a Curagen?

One possibility is to ignore everything I said two paragraphs back and take a large short position in a sector index fund or exchange traded fund (ETF). This makes sense insofar as a big downward movement in the biotech or life sciences sector will be reflected in poor performance of the index or the ETF.

The problem with that strategy is that sector indices are often poor reflections of your underlying portfolio. If I were to try to hedge my portfolio, which consists of approximately 40 small and microcap names, with a sector index or ETF, I would be hedging small cap with large cap. The available indices for biotechnology are disproportionately weighted with companies like Gilead (GILD), Biogen Idec (BIIB), Celgene (CELG) and Amgen (AMGN). These stocks move in very different ways than my predominantly pre-revenue, early-stage, small-cap names. This trade could easily blow up if, whether or not the market for biotech rose or fell, a megamerger of a large pharma company and one of a large biotech companies were to occur, or if a company like Alexion (ALXN) were to be acquired. Further, the cash flow positive names that populate the indices are easy to fit into the discounted cash flow equations that analysts rely upon for price targets. This results in stock price movements that remain confined to more narrow bands than the price movements of my small cap names.

So how about choosing a portfolio of the similarly market cap weighted names that we think are fundamentally weaker, selling those names short, and moving to a more normal market neutral portfolio where our short exposure matches are long exposure?

This theoretically sound strategy, like the index hedging strategy we discussed, is much more difficult in practice than in theory.

Without naming any names, we all know companies whose weak fundamentals seem to disconnect from their share price performance. The stock market is an irrationally irrational place, and expecting engineering-type cause-and-effect relationships is an exercise in frustration. This is a particularly acute problem when identifying small company stocks to sell short. The most disastrous long position will lose 100% of its value, assuming it was bought without leverage (a rule that I feel every small cap investor should follow.) A disastrous short sale, on the other hand, is truly a house on fire.

The market can irrationally price a stock at five dollars a share, and then cruelly punish those rational value investors who, clutching their worn copies of Benjamin Graham’s “The Intelligent Investor,” short the stock at 5 and watch the market irrationally push stock price to 10, or 15 or higher. And, unlike a long position which grows less painful as it goes against you since each percentage movement in the wrong direction chips away at shrinking principle, a short position gets more and more and more painful the longer it stubbornly refuses to go by the book.

Even we fundamental investors try to avoid short squeezes.

So you want to know what to do to prevent your portfolio from doing a Curagen?

Part two to come.

(By the way, I don’t mean to pick on Curagen, which was actually founded by brilliant people and did some good for the world during its corporate life. I just needed a scary chart from a company that no longer trades.)

Source: Forbes Business

 
Update
1

16 hours ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

13 die of Ebola in DRC
Kinshasa, Aug 29 (IANS) A total of 13 people, including five doctors, died of Ebola virus disease in the Democratic Republic of Congo (DRC), the country's Minister of Public Health Felix Kabange told Xinhua Friday.
 
 
How birds learnt to fly
New York, Aug 29 (IANS) Birds have an innate ability to maneuver in mid-air, a talent that could have helped their ancestors learn to fly rather than fall from a perch, says a study.
 
 
Millions of mites crawling on your face right now!
New York, Aug 29 (IANS) Are you aware that your face is brimming with living mites that feed on the oil our skin secretes and hide in tiny hair follicles? And no, they are not pooping on you as they store up all the excreta until they die!
 
 
New tool maps how drug abuse affects brain
Washington, Aug 29 (IANS) In a first, researchers have developed a laser-based imaging tool to map how drug abuse disrupts blood flow to the brain.
 
 
 

Latest from the Network

13 die of Ebola in DRC
Kinshasa, Aug 29 (IANS) A total of 13 people, including five doctors, died of Ebola virus disease in the Democratic Republic of Congo (DRC), the country's Minister of Public Health Felix Kabange told Xinhua Friday....
Read more on Business Balla
 
Bahrain to help treat Gaza injured
Dubai, Aug 29 (IANS) Bahrain will help 100 people injured in Israeli strikes on Gaza to get treatment in Egypt, a media report said Friday. Bahrain has pledged $150,000 to fly 100 injured people from Gaza to Egypt for...
Read more on Politics Balla
 
Carey, Cannon take off their wedding rings
New York, Aug 29 (IANS) Singer Mariah Carey and her estranged husband Nick Cannon were spotted sans their wedding rings. On Tuesday, the singer was seen at a restaurant here without her wedding ring. She was...
Read more on Celebrity Balla
 
Israeli youth dies of wounds from Gaza rocket fire
Jerusalem, Aug 29 (IANS) A 22 year-old Israeli who was severely wounded from a rocket attack in south-central Israel succumbed to his wounds Friday, media reported. Netanel Maman from Gan Yavne was being hospitalised...
Read more on Politics Balla
 
Haven't sought army's mediation in political crisis: Sharif
Islamabad, Aug 29 (IANS) Pakistan Prime Minister Nawaz Sharif Friday told parliament that he has not sought the army's mediation in the current political crisis as was claimed by two opposition leaders whose activists...
Read more on Politics Balla
 
South Asian nations join hands to eradicate wildlife crime
Kathmandu, Aug 29 (IANS) The three-day Second Annual Meeting of the South Asia Wildlife Enforcement Network (SAWEN) ended here Friday with a call for strengthening cooperation in the fight against wildlife crime across...
Read more on Politics Balla
 
Chinchillas named after Pitt, Jolie
Los Angeles, Aug 29 (IANS) Animal rights group PETA has named a pair of rescued chinchillas after Hollywood couple Angelina Jolie and Brad Pitt, who got married at the weekend, as a gift to mark the occasion. The...
Read more on Celebrity Balla
 
Sindhu creates history, enters semis at Worlds
Copenhagen, Aug 29 (IANS) Leading Indian shuttler P.V. Sindhu created history Friday by reaching the women's singles semi-finals and assuring herself of at least a bronze medal finish at the World Championships here....
Read more on Sport Balla
 
Ban, UN Council deplore detention of peacekeepers
United Nations, Aug 29 (IANS/WAM) UN Secretary-General Ban Ki-moon and the Security Council have strongly condemned the detention of UN peacekeepers serving in the Golan amid increased fighting in the area between...
Read more on Politics Balla
 
Comedienne Joan Rivers in medically-induced coma
New York, Aug 29 (IANS) Comedienne Joan Rivers has been placed in a medically-induced coma after suffering cardiac and respiratory failure during a medical procedure. Rivers, 81, was getting her vocal cords checked at...
Read more on Celebrity Balla